MENU
ALDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aldeyra Therapeutics (ALDX) Ownership - Who owns Aldeyra Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
131 Hartwell Avenue
Phone
+1 781 761-4904
Employees
10
Web
https://www.aldeyra.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
301.32M
P/E Ratio
N/A
Total Cash
112.74M
Projected Growth
N/A
Total Debt
15.61M
Revenue
N/A
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash/Share
1.89
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ALDX
Capitalization
301M
P/E Ratio
N/A
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash
113M
Total Cash/Share
1.89
Total Debt
15.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
85.1M
P/B Ratio
3.73
Cash Flow
N/A
Earnings
-0.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
59.6K
Current Ratio
6.80
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-42.57M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.86
Shares Held By Institutions
222M
Shares Outstanding - Current
59.5M
Total Liabilities
32.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
51.852
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics for eye diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
131 Hartwell Avenue
Phone
+1 781 761-4904
Employees
10
Web
https://www.aldeyra.com